Leerink Partnrs Downgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Hold

Leerink Partnrs downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a strong-buy rating to a hold rating in a research report report published on Thursday,Zacks.com reports.

Other analysts have also issued research reports about the stock. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Needham & Company LLC dropped their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Barrington Research cut their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday. Finally, StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday. Six research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Stock Up 3.5 %

Shares of NASDAQ XRAY traded up $0.60 during trading on Thursday, hitting $17.86. 9,705,924 shares of the company traded hands, compared to its average volume of 3,115,189. The firm has a market capitalization of $3.62 billion, a price-to-earnings ratio of -8.63, a P/E/G ratio of 1.31 and a beta of 1.02. The business’s fifty day moving average is $24.68 and its 200 day moving average is $25.90. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same period in the prior year, the business earned $0.49 EPS. The firm’s revenue for the quarter was up .4% on a year-over-year basis. Equities research analysts predict that DENTSPLY SIRONA will post 1.98 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Raymond James Trust N.A. raised its holdings in shares of DENTSPLY SIRONA by 4.9% in the 2nd quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock worth $241,000 after purchasing an additional 453 shares during the period. State of Alaska Department of Revenue boosted its position in DENTSPLY SIRONA by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after purchasing an additional 560 shares during the period. LRI Investments LLC raised its position in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the period. Diversified Trust Co lifted its stake in shares of DENTSPLY SIRONA by 3.0% during the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock valued at $489,000 after buying an additional 566 shares in the last quarter. Finally, Allworth Financial LP grew its stake in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 625 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.